Alternatives to Diagnostics.ai

Comprehensive whole-genome monitoring for cancer recurrence and progression.

Visby Medical develops and manufactures instrument-free, PCR-quality rapid diagnostic tests for infectious diseases at the point of care.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

Develops a computational model of the human body for drug discovery and development.

Genoox provides a cloud-based AI platform for genomic data analysis, connecting clinicians and healthcare organizations.

Data-driven drug discovery and development company using machine learning and high-throughput biology.

MeMed develops and commercializes host immune response diagnostic solutions to address complex clinical dilemmas and improve patient outcomes.

Scopio Labs transforms cell morphology analysis with fully digital platforms and diagnostic support for faster, more accurate disease detection.

Firefly Neuroscience provides objective brain function assessments for mental illness using FDA-cleared Brain Network Analytics (BNA™) technology.

Nucleix is a liquid biopsy company developing early cancer detection solutions using methylation analysis.

Biotech company using AI and deep RNA analysis to predict cancer treatment response.

Harnessing genetic data for digital insights in rare and germline disorders.

Developing a liquid biopsy blood test for early disease detection and monitoring using epigenetic information.

MedHub-AI develops an AI-based decision support system for interventional cardiologists to enable precision cardiac care.

Scent-based multi-cancer early detection screening test using AI and bio-detectors.

AI-powered tele-stroke platform for advanced stroke diagnosis and disease management.

Digital pathology imaging technology and AI-driven precision pathology software.

Develops AI-powered decision support tools for personalized medical data interpretation and prediction.